Editor of Patient Care Online.
Study Shows High Rate of Eczema Type Overlap: Daily Dose
Your daily dose of the clinical news you may have missed.
Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose
RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds
AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.
Closing the Gap in Lung Cancer Screening: Overcoming Barriers, Improving Early Detection
ACP 2025: Kim Sandler, MD, outlines key strategies to boost lung cancer screening uptake in primary care.
Antibiotic Overuse for Asymptomatic UTIs: Daily Dose
Navigating GLP-1 Medication Access: Coverage Challenges, Emerging Cash-Pay Options
ACP 2025: Laura Davisson, MD, outlines how PCPs can navigate GLP-1 medication coverage issues and why to consider recent cash-pay options.
Bringing Mental Health into Primary Care: A Conversation with Matthew Press, MD
ACP 2025: Dr Press explains how primary care clinicians can implement the collaborative care model to integrate mental health services, improve outcomes, and navigate reimbursement.
Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose
Shared Decision-Making in Lung Cancer Screening: A Collaborative Approach
ACP 2025: Kim Sandler, MD, explains how primary care physicians can use shared decision-making to guide patients through lung cancer screening, emphasizing risk, benefit, follow-up, and smoking cessation.
Benefits of Lung Cancer Screening: A Conversation with Kim Sandler, MD
ACP 2025: Kim Sandler, MD, sat down with Patient Care to discuss the benefits of lung cancer screening, citing a 20% reduction in lung cancer mortality with annual screenings.
FDA Approves Gepotidacin for Treatment of Uncomplicated UTIs: Daily Dose
Switching to Tirzepatide Outweighs Escalating Dulaglutide Dose in T2D: SURPASS-SWITCH Trial
Breaking research presented at ACP Internal Medicine 2025 showed that switching GLP1-RAs resulted in better glucose and weight control among adults with inadequately controlled T2D.
Lung Cancer Screening: A Missed Opportunity for Early Detection
ACP 2025: Kim Sandler, MD, discussed the latest screening guidelines, real-world challenges in implementation, and the essential role of shared decision-making.
Universal Syphilis Screening in the ED Outperforms Targeted Approaches: Daily Dose
Alopecia Management in Primary Care: Expert Insights from ACP 2025
William Lewis, MD, discussed the importance of photo-documentation, referral indicators, efficacy of various treatments, and other topics.
ACP: Invest in Rural Communities to Decrease Health Disparities, Improve Access to Care
In a new position paper, the ACP calls for policy action to address rural health disparities, improve access to care, and strengthen the rural health care workforce.
Responsive Parenting Intervention Curbs Childhood Obesity Risk: Daily Dose
Osteoporosis Screening Misses Younger Postmenopausal Women: Daily Dose
ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study
Semaglutide 2.4 mg significantly lowered the risk of MACE and mortality in patients with ASCVD and overweight or obesity but without diabetes, researchers reported.
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.
Uneven US Cancer Screening Recovery Post-COVID: Daily Dose
FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis
The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.
CagriSema Achieves Significant Weight Loss in Phase 3 Trial: Daily Dose
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.
Cleveland Clinic Researchers Develop Risk-Prediction Model for Early-Onset Colorectal Cancer in Young Adults
The model identified BMI, tobacco use, and family history of CRC as the strongest predictors for advanced neoplasia in young adults.
Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose
April Issue of Patient Care Digital Edition is Now Live
The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.
Decline in Smoking Averted Nearly 4 Million Lung Cancer Deaths in the US, Study Estimates
The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.
Better CV Health Tied to Lower Neurodegeneration Risk: Daily Dose
Underutilization of Guideline-Recommended Epinephrine in Anaphylaxis Management: New Study
A 5-year study conducted in Germany showed only 7% of adults and 8% of children with severe anaphylaxis received epinephrine.
